Skip to main content
Erschienen in:

11.08.2023 | Research

Accuracy of the Discriminatory Ability of Combined Fecal Microbiota Panel in the Early Detection of Patients with Colorectal Cancer

verfasst von: Maedeh Amini, Sama Rezasoltani, Hamid Asadzadeh Aghdaei, Mohamad Amin Pourhoseingholi, Mohammad Reza Zali

Erschienen in: Journal of Gastrointestinal Cancer | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Abstract

Background

Colorectal cancer (CRC) screening and detecting it at an early stage is an effective way to decrease mortality from CRC. Colonoscopy, considered the gold standard (GS) for diagnosing the disease in many countries, has several limitations. Therefore, the main focus of this literature is to investigate the ability of combining candidate gut microbiota for early diagnosis of CRC, both in the presence and absence of GS test outcomes.

Methods

We analyzed the data derived from a case-control study, including 83 screening colonoscopies conducted on subjects aged 18–92 years in Tehran, Iran. The candidate gut microbiota including, ETBF, Enterococcus faecalis, and Porphyromonas gingivalis were quantified in samples using absolute qRT PCR. The Bayesian latent class model (LCM) was employed to combine the values from the multiple bacterial markers in order to optimize the discriminatory ability compared with a single marker.

Results

Based on Bayesian logistic regression, we discovered that family history of CRC, physical activity, cigarette smoking, and food diet were all significantly associated with an increased risk of CRC. When comparing ETBF and E. faecalis to P. gingivalis, we have observed that P. gingivalis exhibited greater predictive power in detecting high-risk individuals with CRC. As such, the sensitivity, specificity, and the area under the receiver-operating characteristics curve of combining ETBF, E. faecalis, and P. gingivalis were 98%, 96%, and 0.97, respectively.

Conclusions

This study suggests that the combined use of the three markers markedly improves classification performance compared to pairwise combinations, as well as individual markers, both with and without GS test outcomes. Noticeably, the triple composition of the fecal markers may serve as a reliable non-invasive indicator for the early prediction of CRC.
Literatur
1.
Zurück zum Zitat Bujang N-N-A, Lee Y-J, Mohd-Zain S-A-S, Aris J-H, Md-Yusoff F-A, Suli Z, et al. Factors associated with colorectal cancer screening via immunochemical fecal occult blood test in an average-risk population from a multiethnic, middle-income setting. JCO Glob Oncol. 2021;7(1):333–41. Bujang N-N-A, Lee Y-J, Mohd-Zain S-A-S, Aris J-H, Md-Yusoff F-A, Suli Z, et al. Factors associated with colorectal cancer screening via immunochemical fecal occult blood test in an average-risk population from a multiethnic, middle-income setting. JCO Glob Oncol. 2021;7(1):333–41.
2.
Zurück zum Zitat Jiang H, Guo W, Huang K, Jiang H, Zhang R, Hu H, et al. Screening of radiotracer for diagnosis of colorectal cancer liver metastasis based on MACC1-SPON2.Abdom Radiol. 2021;46(7):3227–37.CrossRefPubMed Jiang H, Guo W, Huang K, Jiang H, Zhang R, Hu H, et al. Screening of radiotracer for diagnosis of colorectal cancer liver metastasis based on MACC1-SPON2.Abdom Radiol. 2021;46(7):3227–37.CrossRefPubMed
3.
Zurück zum Zitat Wong MC, Huang J, Lok V, Wang J, Fung F, Ding H, et al. Differences in incidence and mortality trends of colorectal cancer worldwide based on sex, age, and anatomic location. Clin Gastroenterol Hepatol. 2021;19(5):955–66. e61. Wong MC, Huang J, Lok V, Wang J, Fung F, Ding H, et al. Differences in incidence and mortality trends of colorectal cancer worldwide based on sex, age, and anatomic location. Clin Gastroenterol Hepatol. 2021;19(5):955–66. e61.
4.
Zurück zum Zitat Deo S, Kumar S, Bhoriwal S, Shukla N, Sharma A, Thulkar S, et al. Colorectal cancers in low-and middle-income countries—Demographic pattern and clinical profile of 970 patients treated at a tertiary care cancer center in India. JCO Global Oncol. 2021;7:1110–5.CrossRefPubMed Deo S, Kumar S, Bhoriwal S, Shukla N, Sharma A, Thulkar S, et al. Colorectal cancers in low-and middle-income countries—Demographic pattern and clinical profile of 970 patients treated at a tertiary care cancer center in India. JCO Global Oncol. 2021;7:1110–5.CrossRefPubMed
5.
Zurück zum Zitat Cao Y, Zhao G, Yuan M, Liu X, Ma Y, Cao Y, et al. KCNQ5 and C9orf50 methylation in stool DNA for early detection of colorectal cancer. Front Oncol. 2021;10: 621295.CrossRefPubMedPubMedCentral Cao Y, Zhao G, Yuan M, Liu X, Ma Y, Cao Y, et al. KCNQ5 and C9orf50 methylation in stool DNA for early detection of colorectal cancer. Front Oncol. 2021;10: 621295.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Njor SH, Andersen B, Friis-Hansen L, de Haas N, Linnemann D, Nørgaard H, et al. The optimal cut-off value in fit-based colorectal cancer screening: An observational study. Cancer Med. 2021;10(5):1872–9.CrossRefPubMedPubMedCentral Njor SH, Andersen B, Friis-Hansen L, de Haas N, Linnemann D, Nørgaard H, et al. The optimal cut-off value in fit-based colorectal cancer screening: An observational study. Cancer Med. 2021;10(5):1872–9.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Ramazani AA, Norozi E, AmirabadiZadeh H, Ehteshampour AR, Salehiniya H. Predictors of colorectal cancer screening participation in Southern Khorasan (Iran). J Gastrointest Cancer. 2021;52(1):187–91.CrossRefPubMed Ramazani AA, Norozi E, AmirabadiZadeh H, Ehteshampour AR, Salehiniya H. Predictors of colorectal cancer screening participation in Southern Khorasan (Iran). J Gastrointest Cancer. 2021;52(1):187–91.CrossRefPubMed
8.
Zurück zum Zitat Wu X, Zhang Y, Hu T, He X, Zou Y, Deng Q, et al. A novel cell-free DNA methylation-based model improves the early detection of colorectal cancer. Mol Oncol. 2021;15(10):2702–14.CrossRefPubMedPubMedCentral Wu X, Zhang Y, Hu T, He X, Zou Y, Deng Q, et al. A novel cell-free DNA methylation-based model improves the early detection of colorectal cancer. Mol Oncol. 2021;15(10):2702–14.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Villéger R, Lopès A, Veziant J, Gagnière J, Barnich N, Billard E, et al. Microbial markers in colorectal cancer detection and/or prognosis. World J Gastroenterol. 2018;24(22):2327.CrossRefPubMedPubMedCentral Villéger R, Lopès A, Veziant J, Gagnière J, Barnich N, Billard E, et al. Microbial markers in colorectal cancer detection and/or prognosis. World J Gastroenterol. 2018;24(22):2327.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Su W-C, Kao W-Y, Chang T-K, Tsai H-L, Huang C-W, Chen Y-C, et al. Stool DNA test targeting methylated syndecan-2 (SDC2) as a noninvasive screening method for colorectal cancer. Biosci Rep. 2021;41(1). Su W-C, Kao W-Y, Chang T-K, Tsai H-L, Huang C-W, Chen Y-C, et al. Stool DNA test targeting methylated syndecan-2 (SDC2) as a noninvasive screening method for colorectal cancer. Biosci Rep. 2021;41(1).
11.
Zurück zum Zitat Wu Y, Yang X, Jiang G, Zhang H, Ge L, Chen F, et al. 5′-tRF-GlyGCC: A tRNA-derived small RNA as a novel biomarker for colorectal cancer diagnosis. Genome medicine. 2021;13(1):1–12.CrossRef Wu Y, Yang X, Jiang G, Zhang H, Ge L, Chen F, et al. 5′-tRF-GlyGCC: A tRNA-derived small RNA as a novel biomarker for colorectal cancer diagnosis. Genome medicine. 2021;13(1):1–12.CrossRef
13.
14.
Zurück zum Zitat Zhang W, Xiao G, Chen J, Wang L, Hu Q, Wu J, et al. Electrochemical biosensors for measurement of colorectal cancer biomarkers. Anal Bioanal Chem. 2021;413(9):2407–28.CrossRefPubMed Zhang W, Xiao G, Chen J, Wang L, Hu Q, Wu J, et al. Electrochemical biosensors for measurement of colorectal cancer biomarkers. Anal Bioanal Chem. 2021;413(9):2407–28.CrossRefPubMed
15.
Zurück zum Zitat Lee K, Seo H, Choe S, Jeong S-Y, Park JW, Suh M, et al. Intentions to undergo primary screening with colonoscopy under the National Cancer Screening Program in Korea. PLoS ONE. 2021;16(2):e0247252.CrossRefPubMedPubMedCentral Lee K, Seo H, Choe S, Jeong S-Y, Park JW, Suh M, et al. Intentions to undergo primary screening with colonoscopy under the National Cancer Screening Program in Korea. PLoS ONE. 2021;16(2):e0247252.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Pellino G, Gallo G, Pallante P, Capasso R, De Stefano A, Maretto I, et al. Noninvasive biomarkers of colorectal cancer: Role in diagnosis and personalised treatment perspectives. Gastroenterology Res Pract. 2018;2018. Pellino G, Gallo G, Pallante P, Capasso R, De Stefano A, Maretto I, et al. Noninvasive biomarkers of colorectal cancer: Role in diagnosis and personalised treatment perspectives. Gastroenterology Res Pract. 2018;2018.
17.
Zurück zum Zitat Peterse EF, Meester RG, de Jonge L, Omidvari A-H, Alarid-Escudero F, Knudsen AB, et al. Comparing the cost-effectiveness of innovative colorectal cancer screening tests. JNCI: J Natl Cancer Inst. 2021;113(2):154–61. Peterse EF, Meester RG, de Jonge L, Omidvari A-H, Alarid-Escudero F, Knudsen AB, et al. Comparing the cost-effectiveness of innovative colorectal cancer screening tests. JNCI: J Natl Cancer Inst. 2021;113(2):154–61.
18.
Zurück zum Zitat Liu W, Zhang R, Shu R, Yu J, Li H, Long H, et al. Study of the relationship between microbiome and colorectal cancer susceptibility using 16SrRNA sequencing. BioMed Res Int. 2020;2020. Liu W, Zhang R, Shu R, Yu J, Li H, Long H, et al. Study of the relationship between microbiome and colorectal cancer susceptibility using 16SrRNA sequencing. BioMed Res Int. 2020;2020.
19.
Zurück zum Zitat De Almeida CV, Lulli M, di Pilato V, Schiavone N, Russo E, Nannini G, et al. Differential responses of colorectal cancer cell lines to Enterococcus faecalis’ strains isolated from healthy donors and colorectal cancer patients. J Clin Med. 2019;8(3):388.CrossRefPubMedPubMedCentral De Almeida CV, Lulli M, di Pilato V, Schiavone N, Russo E, Nannini G, et al. Differential responses of colorectal cancer cell lines to Enterococcus faecalis’ strains isolated from healthy donors and colorectal cancer patients. J Clin Med. 2019;8(3):388.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Zamani S, Taslimi R, Sarabi A, Jasemi S, Sechi LA, Feizabadi MM. Enterotoxigenic Bacteroides fragilis: A possible etiological candidate for bacterially-induced colorectal precancerous and cancerous lesions. Front Cell Infect Microbiol. 2020;9:449.CrossRefPubMedPubMedCentral Zamani S, Taslimi R, Sarabi A, Jasemi S, Sechi LA, Feizabadi MM. Enterotoxigenic Bacteroides fragilis: A possible etiological candidate for bacterially-induced colorectal precancerous and cancerous lesions. Front Cell Infect Microbiol. 2020;9:449.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Bao Y, Tang J, Qian Y, Sun T, Chen H, Chen Z, et al. Long noncoding RNA BFAL1 mediates enterotoxigenic Bacteroides fragilis-related carcinogenesis in colorectal cancer via the RHEB/mTOR pathway. Cell Death Dis. 2019;10(9):1–14.CrossRef Bao Y, Tang J, Qian Y, Sun T, Chen H, Chen Z, et al. Long noncoding RNA BFAL1 mediates enterotoxigenic Bacteroides fragilis-related carcinogenesis in colorectal cancer via the RHEB/mTOR pathway. Cell Death Dis. 2019;10(9):1–14.CrossRef
22.
Zurück zum Zitat Lafuente Ibáñez de Mendoza I, Maritxalar Mendia X, Garcia de la Fuente AM, Quindos Andres G, Aguirre Urizar JM. Role of Porphyromonas gingivalis in oral squamous cell carcinoma development: A systematic review. J Periodontal Res. 2020;55(1):13–22. Lafuente Ibáñez de Mendoza I, Maritxalar Mendia X, Garcia de la Fuente AM, Quindos Andres G, Aguirre Urizar JM. Role of Porphyromonas gingivalis in oral squamous cell carcinoma development: A systematic review. J Periodontal Res. 2020;55(1):13–22.
23.
Zurück zum Zitat Rodríguez IT, Ballart JF, Pastor GC, Jorda EB, Val VA. Validation of a short questionnaire on frequency of dietary intake: Reproducibility and validity. Nutr Hosp. 2008;23(3):242–52.PubMed Rodríguez IT, Ballart JF, Pastor GC, Jorda EB, Val VA. Validation of a short questionnaire on frequency of dietary intake: Reproducibility and validity. Nutr Hosp. 2008;23(3):242–52.PubMed
24.
Zurück zum Zitat Rezasoltani S, Sharafkhah M, Aghdaei HA, Mojarad EN, Dabiri H, Sepahi AA, et al. Applying simple linear combination, multiple logistic and factor analysis methods for candidate fecal bacteria as novel biomarkers for early detection of adenomatous polyps and colon cancer. J Microbiol Methods. 2018;155:82–8.CrossRefPubMed Rezasoltani S, Sharafkhah M, Aghdaei HA, Mojarad EN, Dabiri H, Sepahi AA, et al. Applying simple linear combination, multiple logistic and factor analysis methods for candidate fecal bacteria as novel biomarkers for early detection of adenomatous polyps and colon cancer. J Microbiol Methods. 2018;155:82–8.CrossRefPubMed
25.
Zurück zum Zitat Collins J, Albert PS. Estimating diagnostic accuracy without a gold standard: A continued controversy. J Biopharm Stat. 2016;26(6):1078–82.CrossRefPubMed Collins J, Albert PS. Estimating diagnostic accuracy without a gold standard: A continued controversy. J Biopharm Stat. 2016;26(6):1078–82.CrossRefPubMed
26.
Zurück zum Zitat Pereira GdA, Louzada F, Barbosa VdF, Ferreira-Silva MM, Moraes-Souza H. A general latent class model for performance evaluation of diagnostic tests in the absence of a gold standard: An application to Chagas disease. Comput Math Methods Med. 2012;2012. Pereira GdA, Louzada F, Barbosa VdF, Ferreira-Silva MM, Moraes-Souza H. A general latent class model for performance evaluation of diagnostic tests in the absence of a gold standard: An application to Chagas disease. Comput Math Methods Med. 2012;2012.
27.
Zurück zum Zitat Pepe MS, Janes H. Insights into latent class analysis of diagnostic test performance. Biostatistics. 2007;8(2):474–84.CrossRefPubMed Pepe MS, Janes H. Insights into latent class analysis of diagnostic test performance. Biostatistics. 2007;8(2):474–84.CrossRefPubMed
28.
Zurück zum Zitat Qin J, Zhang B. Best combination of multiple diagnostic tests for screening purposes. Stat Med. 2010;29(28):2905–19.CrossRefPubMed Qin J, Zhang B. Best combination of multiple diagnostic tests for screening purposes. Stat Med. 2010;29(28):2905–19.CrossRefPubMed
29.
Zurück zum Zitat Yu B, Zhou C, Bandinelli S. Combining multiple continuous tests for the diagnosis of kidney impairment in the absence of a gold standard. Stat Med. 2011;30(14):1712–21.CrossRefPubMedPubMedCentral Yu B, Zhou C, Bandinelli S. Combining multiple continuous tests for the diagnosis of kidney impairment in the absence of a gold standard. Stat Med. 2011;30(14):1712–21.CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Keku TO, Dulal S, Deveaux A, Jovov B, Han X. The gastrointestinal microbiota and colorectal cancer. Am J Physiol Gastrointest Liver Physiol. 2015;308(5):G351-G63. Keku TO, Dulal S, Deveaux A, Jovov B, Han X. The gastrointestinal microbiota and colorectal cancer. Am J Physiol Gastrointest Liver Physiol. 2015;308(5):G351-G63.
31.
Zurück zum Zitat Haghi F, Goli E, Mirzaei B, Zeighami H. The association between fecal enterotoxigenic B. fragilis with colorectal cancer. BMC Cancer. 2019;19(1):1–4. Haghi F, Goli E, Mirzaei B, Zeighami H. The association between fecal enterotoxigenic B. fragilis with colorectal cancer. BMC Cancer. 2019;19(1):1–4.
32.
Zurück zum Zitat Vacante M, Ciuni R, Basile F, Biondi A. Gut microbiota and colorectal cancer development: A closer look to the adenoma-carcinoma sequence. Biomedicines. 2020;8(11):489.CrossRefPubMedPubMedCentral Vacante M, Ciuni R, Basile F, Biondi A. Gut microbiota and colorectal cancer development: A closer look to the adenoma-carcinoma sequence. Biomedicines. 2020;8(11):489.CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Khan Z, Siddiqui N, Saif MW. Enterococcus faecalis infective endocarditis and colorectal carcinoma: Case of new association gaining ground. Gastroenterology Res. 2018;11(3):238.CrossRefPubMedPubMedCentral Khan Z, Siddiqui N, Saif MW. Enterococcus faecalis infective endocarditis and colorectal carcinoma: Case of new association gaining ground. Gastroenterology Res. 2018;11(3):238.CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Liu X-b, Gao Z-y, Sun C-t, Wen H, Gao B, Li S-b, et al. The potential role of P. gingivalis in gastrointestinal cancer: A mini review. Infectious Agents and Cancer. 2019;14(1):1–7. Liu X-b, Gao Z-y, Sun C-t, Wen H, Gao B, Li S-b, et al. The potential role of P. gingivalis in gastrointestinal cancer: A mini review. Infectious Agents and Cancer. 2019;14(1):1–7.
35.
Zurück zum Zitat Kim M, Lee S-T, Choi S, Lee H, Kwon SS, Byun JH, et al. Fusobacterium nucleatum in biopsied tissues from colorectal cancer patients and alcohol consumption in Korea. Sci Rep. 2020;10(1):1–10. Kim M, Lee S-T, Choi S, Lee H, Kwon SS, Byun JH, et al. Fusobacterium nucleatum in biopsied tissues from colorectal cancer patients and alcohol consumption in Korea. Sci Rep. 2020;10(1):1–10.
36.
Zurück zum Zitat Purcell RV, Pearson J, Aitchison A, Dixon L, Frizelle FA, Keenan JI. Colonization with enterotoxigenic Bacteroides fragilis is associated with early-stage colorectal neoplasia. PLoS ONE. 2017;12(2):e0171602.CrossRefPubMedPubMedCentral Purcell RV, Pearson J, Aitchison A, Dixon L, Frizelle FA, Keenan JI. Colonization with enterotoxigenic Bacteroides fragilis is associated with early-stage colorectal neoplasia. PLoS ONE. 2017;12(2):e0171602.CrossRefPubMedPubMedCentral
37.
Zurück zum Zitat Oyeyemi SO, Braaten T, Licaj I, Lund E, Benjaminsen BK. Physical activity patterns and the risk of colorectal cancer in the Norwegian Women and Cancer study: A population-based prospective study. BMC Cancer. 2018;18(1):1–11.CrossRef Oyeyemi SO, Braaten T, Licaj I, Lund E, Benjaminsen BK. Physical activity patterns and the risk of colorectal cancer in the Norwegian Women and Cancer study: A population-based prospective study. BMC Cancer. 2018;18(1):1–11.CrossRef
38.
Zurück zum Zitat Luo W-P, Fang Y-J, Lu M-S, Zhong X, Chen Y-M, Zhang C-X. High consumption of vegetable and fruit colour groups is inversely associated with the risk of colorectal cancer: A case–control study. Br J Nutr. 2015;113(7):1129–38.CrossRefPubMed Luo W-P, Fang Y-J, Lu M-S, Zhong X, Chen Y-M, Zhang C-X. High consumption of vegetable and fruit colour groups is inversely associated with the risk of colorectal cancer: A case–control study. Br J Nutr. 2015;113(7):1129–38.CrossRefPubMed
39.
Zurück zum Zitat Morris JS, Bradbury KE, Cross AJ, Gunter MJ, Murphy N. Physical activity, sedentary behaviour and colorectal cancer risk in the UK Biobank. Br J Cancer. 2018;118(6):920–9.CrossRefPubMedPubMedCentral Morris JS, Bradbury KE, Cross AJ, Gunter MJ, Murphy N. Physical activity, sedentary behaviour and colorectal cancer risk in the UK Biobank. Br J Cancer. 2018;118(6):920–9.CrossRefPubMedPubMedCentral
40.
Zurück zum Zitat Khatatbeh MM, Jadallah KA, Bashtawy MA, Hamaydeh SA, Gharaibeh MA, Kanaan NB, et al. Factors associated with colorectal cancer among Jordanians: A case-control study. Asian Pacific Journal of Cancer Prevention: APJCP. 2018;19(2):577.PubMedPubMedCentral Khatatbeh MM, Jadallah KA, Bashtawy MA, Hamaydeh SA, Gharaibeh MA, Kanaan NB, et al. Factors associated with colorectal cancer among Jordanians: A case-control study. Asian Pacific Journal of Cancer Prevention: APJCP. 2018;19(2):577.PubMedPubMedCentral
41.
Zurück zum Zitat Miles L. Physical activity and the prevention of cancer: A review of recent findings. Nutr Bull. 2007;32(3):250–82.CrossRef Miles L. Physical activity and the prevention of cancer: A review of recent findings. Nutr Bull. 2007;32(3):250–82.CrossRef
42.
Zurück zum Zitat Zhou X-Y, Yan L, Wang L-L, Wang J. Association between physical activity and colorectal cancer risk and prognosis: A meta-analysis. Cancer Treat Res Commun. 2016;9:62–9.CrossRef Zhou X-Y, Yan L, Wang L-L, Wang J. Association between physical activity and colorectal cancer risk and prognosis: A meta-analysis. Cancer Treat Res Commun. 2016;9:62–9.CrossRef
43.
Zurück zum Zitat Shaw E, Farris MS, Stone CR, Derksen JW, Johnson R, Hilsden RJ, et al. Effects of physical activity on colorectal cancer risk among family history and body mass index subgroups: A systematic review and meta-analysis. BMC Cancer. 2018;18(1):1–15.CrossRef Shaw E, Farris MS, Stone CR, Derksen JW, Johnson R, Hilsden RJ, et al. Effects of physical activity on colorectal cancer risk among family history and body mass index subgroups: A systematic review and meta-analysis. BMC Cancer. 2018;18(1):1–15.CrossRef
44.
Zurück zum Zitat Hannan LM, Jacobs EJ, Thun MJ. The association between cigarette smoking and risk of colorectal cancer in a large prospective cohort from the United States. Cancer Epidemiol Biomark Prev. 2009;18(12):3362–7.CrossRef Hannan LM, Jacobs EJ, Thun MJ. The association between cigarette smoking and risk of colorectal cancer in a large prospective cohort from the United States. Cancer Epidemiol Biomark Prev. 2009;18(12):3362–7.CrossRef
45.
Zurück zum Zitat Luchtenborg M, White KK, Wilkens L, Kolonel LN, Le Marchand L. Smoking and colorectal cancer: Different effects by type of cigarettes? Cancer Epidemiol Biomark Prev. 2007;16(7):1341–7.CrossRef Luchtenborg M, White KK, Wilkens L, Kolonel LN, Le Marchand L. Smoking and colorectal cancer: Different effects by type of cigarettes? Cancer Epidemiol Biomark Prev. 2007;16(7):1341–7.CrossRef
46.
Zurück zum Zitat Peppone LJ, Hyland A, Moysich KB, Reid ME, Piazza KM, Purnell JQ, et al. Examining the association between cigarette smoking and colorectal cancer using historical case–control data. Cancer Epidemiol. 2009;33(3–4):182–8.CrossRefPubMedPubMedCentral Peppone LJ, Hyland A, Moysich KB, Reid ME, Piazza KM, Purnell JQ, et al. Examining the association between cigarette smoking and colorectal cancer using historical case–control data. Cancer Epidemiol. 2009;33(3–4):182–8.CrossRefPubMedPubMedCentral
47.
Zurück zum Zitat Wei P-L, Lin S-Y, Chang Y-J. Cigarette smoking and colorectal cancer: From epidemiology to bench. J Exp Clin Med. 2011;3(6):257–61.CrossRef Wei P-L, Lin S-Y, Chang Y-J. Cigarette smoking and colorectal cancer: From epidemiology to bench. J Exp Clin Med. 2011;3(6):257–61.CrossRef
48.
Zurück zum Zitat Lee S, Woo H, Lee J, Oh J-H, Kim J, Shin A. Cigarette smoking, alcohol consumption, and risk of colorectal cancer in South Korea: A case-control study. Alcohol. 2019;76:15–21.CrossRefPubMed Lee S, Woo H, Lee J, Oh J-H, Kim J, Shin A. Cigarette smoking, alcohol consumption, and risk of colorectal cancer in South Korea: A case-control study. Alcohol. 2019;76:15–21.CrossRefPubMed
49.
Zurück zum Zitat Golshiri P, Rasooli S, Emami M, Najimi A. Effects of physical activity on risk of colorectal cancer: A case–control study. Int J Prev Med. 2016;7. Golshiri P, Rasooli S, Emami M, Najimi A. Effects of physical activity on risk of colorectal cancer: A case–control study. Int J Prev Med. 2016;7.
50.
Zurück zum Zitat Bante SA, Getie SA, Getu AA, Mulatu K, Fenta SL. Uptake of pre-cervical cancer screening and associated factors among reproductive age women in Debre Markos town, Northwest Ethiopia, 2017. BMC Public Health. 2019;19(1):1–9.CrossRef Bante SA, Getie SA, Getu AA, Mulatu K, Fenta SL. Uptake of pre-cervical cancer screening and associated factors among reproductive age women in Debre Markos town, Northwest Ethiopia, 2017. BMC Public Health. 2019;19(1):1–9.CrossRef
51.
Zurück zum Zitat van Smeden M, Naaktgeboren CA, Reitsma JB, Moons KG, de Groot JA. Latent class models in diagnostic studies when there is no reference standard—A systematic review. Am J Epidemiol. 2014;179(4):423–31.CrossRefPubMed van Smeden M, Naaktgeboren CA, Reitsma JB, Moons KG, de Groot JA. Latent class models in diagnostic studies when there is no reference standard—A systematic review. Am J Epidemiol. 2014;179(4):423–31.CrossRefPubMed
Metadaten
Titel
Accuracy of the Discriminatory Ability of Combined Fecal Microbiota Panel in the Early Detection of Patients with Colorectal Cancer
verfasst von
Maedeh Amini
Sama Rezasoltani
Hamid Asadzadeh Aghdaei
Mohamad Amin Pourhoseingholi
Mohammad Reza Zali
Publikationsdatum
11.08.2023
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Cancer / Ausgabe 1/2024
Print ISSN: 1941-6628
Elektronische ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-023-00962-z

Neu im Fachgebiet Onkologie

Studie zur HIFU bei Prostatakrebs lässt viele Fragen offen

Führt eine HIFU-Ablation beim Prostatakarzinom im Vergleich mit einer radikalen Prostatektomie zu ähnlichen onkologischen, aber besseren funktionalen Ergebnissen? Interimsdaten der französischen HIFI-Studie sind uneindeutig. In einem Kommentar zur Studie werden zumindest drei allgemeine Erkenntnisse herausgearbeitet.

Bei Achalasie auf Candidiasis der Speiseröhre achten!

Bei Achalasie-Betroffenen sollte man immer auch auf Candida-Infektionen achten, warnen Forschende aus Rotterdam. In ihrer Studie ließ die Pilzinfektion das Risiko für ein Ösophaguskarzinom massiv steigen.

Adipositas als negativer Prognosefaktor bei Kindern mit Krebs

Eine kanadische Studie weist darauf hin, dass Übergewicht zum Zeitpunkt der Krebsdiagnose ein unabhängiger Risikofaktor für schlechtere Überlebenschancen bei erkrankten Kindern und Jugendlichen sein könnte. Allerdings sind nicht alle Patientinnen und Patienten gleichermaßen betroffen.


Polypen bei nahen Verwandten – erhöhtes Darmkrebsrisiko

Werden bei erstgradigen Verwandten gutartige Darmpolypen identifiziert, ist das Risiko, selbst an einem Kolorektalkarzinom zu erkranken, deutlich erhöht – vor allem das für eine früh beginnende Erkrankung. Hier könnte sich eine frühe Koloskopie besonders lohnen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.